Search International and National Patent Collections

1. (WO2017037280) FUSION PROTEIN

Pub. No.:    WO/2017/037280    International Application No.:    PCT/EP2016/070824
Publication Date: Fri Mar 10 00:59:59 CET 2017 International Filing Date: Tue Sep 06 01:59:59 CEST 2016
IPC: A61K 39/29
A61K 39/36
C12N 15/62
A61P 31/20
Applicants: VIRAVAXX AG
Inventors: VALENTA, Rudolf
The present invention relates to a fusion protein for use in the treatment and/or prevention of a hepatitis B virus infection comprising at least one hepatitis B PreS polypeptide or fragment thereof fused to at least one peptide consisting of an amino acid sequence having at least 80% identity to a sequence selected from the group consisting of SEQ ID No. 1, SEQ ID No. 2, SEQ ID No. 3 and SEQ ID No. 4.